The Pharmaceutical Industry in Ethiopia

Content Type: Reports
Author(s): HealthTech
Published: August 2012

HealthTech conducted desk research to understand the global pharmaceutical landscape for 4% chlorhexidine (7.1% chlorhexidine gluconate) for umbilical cord care (the CHX Product) in order to
facilitate discussions regarding the optimal production strategy for global roll-out of this product at a collaborators’ meeting held in Washington, DC, on July 19 and 20, 2012. As part of this research, we asked partners and experts to provide information from two selected countries, Ethiopia and Pakistan, to augment existing information.

Download Resource
File Type: PDF (401.96 KB)